AbbVie Recommends Shareholders Reject Mini-Tender Offer for Up to 1.5m Shares at USD 88.05 per Share.

MANews-(C)2009-2020

Chicago, US-based biopharmaceutical company AbbVie (NYSE: ABBV) has been notified that TRC Capital Investment Corp. (TRC Capital) has commenced an unsolicited mini-tender offer, dated June 1, 2020, to purchase up to 1.5m shares of AbbVie common stock at 4.99% below the stock's closing price on May 29 of USD 92.67, the company said.

The mini-tender offer is for USD 88.05 per share.

AbbVie is not associated in any way with TRC Capital, its mini-tender offer, or the offer documentation.

AbbVie does not endorse TRC Capital's offer...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT